Requests of laboratory tests for the diagnosis and management of calcium-phosphate disorders in Spain;Solicitud de pruebas de laboratorio para el diagnóstico y manejo de los desórdenes del metabolismo fosfocálcico en España

Revista Medica de Chile

Volumn 144, Issue 8, 2016, Pages 990-997

  Salinas, María ^a,b   López Garrigós, Maite ^a   Flores, Emilio ^a,b   Uris, Joaquín ^c   Leiva Salinas, Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY OF ALICANTE   (Spain)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Calcium metabolism disorders; Clinical laboratory services; Practice patterns, physicians

Indexed keywords

25-HYDROXYVITAMIN D; CALCIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ANALOGS AND DERIVATIVES; BLOOD; CALCIUM METABOLISM DISORDERS; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LABORATORY TECHNIQUE; MALE; MASS SCREENING; METABOLISM; PRIMARY HEALTH CARE; PROCEDURES; SPAIN; STATISTICS AND NUMERICAL DATA; UTILIZATION;

CALCIUM METABOLISM DISORDERS; CALCIUM PHOSPHATES; CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; FEMALE; GENERAL PRACTITIONERS; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MASS SCREENING; PARATHYROID HORMONE; PHOSPHATES; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; SPAIN; VITAMIN D;

EID: 84998996780     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872016000800005     Document Type: Article

References (34)

1. Evans RA. Hypercalcaemia. What does it signify? Drugs 1986; 31 (1): 64-74.
2. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991; 6 (2): S51-9.
3. Harrison BJ, Wheeler MH. Asymptomatic primary hyperparathyroidism. World J Surg 1991; 15 (6): 724-9.
4. Weber T, Eberle J, Messelhäuser U, Schiffmann L, Nies C, Schabram J, et al. Parathyroidectomy, elevated depresion scores, and suicidal ideation in patients with primary hyperparathyroidism. Results of prospective multicenter study. JAMA Surg 2013; 148 (2): 109-15.
5. Walker MD, Rundek T, Homma S, Di Tullio M, Iwata S, Lee JA, et al. Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. Eur J Endocrinol 2012; 167 (2): 277-85.
6. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93 (9): 3462-70.
7. van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998; 280 (6): 550-8.
8. Salinas M, López-Garrigós M, Uris J, Leiva-Salinas C, Pilot Group of the Appropriate Utilization of Laboratory Tests (REDCONLAB) working group. A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request. Clin Biochem 2014; 47 (12): 1104-7.
9. Rang M. The Ulysses syndrome. Can Med Assoc J 1972; 106 (2): 122-3.
10. Salinas M, López-Garrigós M, Leiva-Salinas C. False positive results: The imaginary invalid syndrome. Aten Primaria 2013; 45 (10): 542.
11. Salinas M, López-Garrigós M, Flors L, Leiva-Salinas C. Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians? Clin Chem Lab Med 2013; 51 (9): e199-200.
12. Salinas M, López-Garrigós M, Díaz J, et al. Regional variations in test requiring patterns of general practitioners in Spain. Ups J Med Sci 2011; 116 (4): 247-51.
13. Salinas M, López-Garrigós M, Tormo C, Ortuño M, Yago M, Laíz B, et al. Primary care use of laboratory tests in Spain: measurement through appropriateness indicators. Clin Lab 2014; 60 (3): 483-90.
14. Salinas M, López-Garrigós M, Pomares F, Lugo J, Asencio A, López-Penabad L, et al. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT). Bone 2013; 56 (1): 73-6.
15. Dalemo S, Hjerpe P, Ohlsson H, Eggertsen R, Merlo J, Boström KB. Variation in plasma calcium analysis in primary care in Sweden-a multilevel analysis. BMC Fam Pract 2010; 30 (11): 43.
16. Dalemo S, Hjerpe P, Boström Bengtsson K. Diagnosis of patients with raised serum calcium level in primary care, Sweden. Scand J Prim Health Care 2006; 24 (3): 160-5.
17. Larsson A, Palmer M, Hultén G, Tryding N. Large differences in laboratory utilisation between hospitals in Sweden. Clin Chem Lab Med 2000; 38 (5): 383-9.
18. Salinas M, López-Garrigós M, Uris J; Pilot Group of the Appropriate Utilization of Laboratory Tests (REDCONLAB) Working Group. Differences in laboratory requesting patterns in emergency department in Spain. Ann Clin Biochem 2013; 50 (4): 353-9.
19. Palmer M, Jakobsson S, Akerström G, Ljunghall S. Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988; 18 (1): 39-46.
20. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand 1976; 200 (1-2): 131-7.
21. Phillips PJ, Pain RW, Hartley TF, Duncan BM, Atkinson MJ. Current “corrected” calcium concept rechallenged. Clin Chem 1977; 23 (10): 1938-9.
22. Dalemo S, Eggertsen R, Hjerpe P, Jansson S, Almqvist EG, Bengtsson Boström K. Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care. Scand J Prim Health Care 2013; 31 (4): 248-54.
23. Bowman WD. Primary hyperparathyroidism. Before and after development of routine screening tests. Rocky Mt Med J 1972; 69 (5): 53-6.
24. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980; 1 (8182): 1317-20.
25. Lundgren E, Rastad J, Thrufjell E, Akerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997; 121 (3): 287-94.
26. Press DM, Siperstein AE, Berber E, Shin JJ, Metzger R, Monteiro R, et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 2013; 154 (6): 1232-7.
27. Janssens L, Verbeke V, Petrossians P, Dubois B, Godon E, Godon JP, et al. Primary hyperparathyroidism: etiology, diagnosis and treatment. Rev Med Liege 2000; 55 (11): 977-85.
28. Muñoz Torres M, Jodar Gimeno E, Reyes García R, Martínez Díaz Guerra G, Amado JA, Gaztambide S, et al. Results from a national survey on the management of primary hyperparathyroidism. J Endocrinol Invest 2012; 35 (11): 957-63.
29. Benson L, Ljunghall S, Groth T, Falk H, Hvarfner A, Rastad J, et al. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements. Ups J Med Sci 1987; 92 (2): 147-76.
30. Orrell DH. Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta 1971; 35 (2): 483-9.
31. Phillips P, Pain R. Correcting the calcium. Br Med J 1977; 1 (6074): 1473.
32. Lepper PM, Dufour JF. Elevated transaminases-what to do if everything was done? Praxis (Bern 1994) 2009; 98 (6): 330-4.
33. Srivastava R, Bartlett WA, Kennedy IM, Hiney A, Fletcher C, Murphy MJ. Reflex and reflective testing: efficiency and effectiveness of adding on laboratory tests. Ann Clin Biochem 2010; 47 (3): 223-7.
34. Brandi ML, Minisola S. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent. Curr Med Res Opin 2013; 29 (11): 1565-72.